Met Life Investment Management, LLC Kronos Bio, Inc. Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 10, 2024	BUY	$3.35 - $5.55 $3,463 - $5,738	1,034 Added 4.21%	25,568 $85,000
Q3 2022 Jun 14, 2023	BUY	$3.35 - $5.55 $85,652 - $141,902	25,568 New	25,568 $85,000
Q3 2022 Mar 22, 2023	BUY	$3.35 - $5.55 $3,463 - $5,738	1,034 Added 4.21%	25,568 $85,000
Q3 2022 Nov 14, 2022	BUY	$3.35 - $5.55 $85,652 - $141,902	25,568 New	25,568 $86,000
Q2 2022 Aug 11, 2022	SELL	$3.12 - $7.52 $76,546 - $184,495	-24,534 Closed	0 $0
Q1 2022 May 10, 2024	BUY	$6.26 - $14.42 $153,582 - $353,780	24,534 New	24,534 $177,000
Q1 2022 Jun 20, 2023	BUY	$6.26 - $14.42 $153,582 - $353,780	24,534 New	24,534 $177,000
Q1 2022 Mar 22, 2023	BUY	$6.26 - $14.42 $56,684 - $130,573	9,055 Added 58.5%	24,534 $177,000
Q1 2022 May 12, 2022	BUY	$6.26 - $14.42 $56,684 - $130,573	9,055 Added 58.5%	24,534 $177,000
Q4 2021 Jun 21, 2023	BUY	$11.35 - $21.18 $175,686 - $327,845	15,479 New	15,479 $210,000
Q3 2021 Jun 21, 2023	BUY	$18.17 - $24.7 $281,253 - $382,331	15,479 New	15,479 $324,000
Q2 2021 May 17, 2024	BUY	$20.08 - $29.02 $172,346 - $249,078	8,583 Added 124.46%	15,479 $370,000
Q2 2021 Jun 21, 2023	BUY	$20.08 - $29.02 $310,818 - $449,200	15,479 New	15,479 $370,000
Q2 2021 Mar 22, 2023	BUY	$20.08 - $29.02 $172,346 - $249,078	8,583 Added 124.46%	15,479 $370,000
Q2 2021 Aug 16, 2021	BUY	$20.08 - $29.02 $172,346 - $249,078	8,583 Added 124.46%	15,479 $371,000
Q1 2021 May 17, 2024	BUY	$27.0 - $32.48 $186,192 - $223,982	6,896 New	6,896 $201,000
Q1 2021 Jun 26, 2023	BUY	$27.0 - $32.48 $186,192 - $223,982	6,896 New	6,896 $202 Million
Q4 2020 May 24, 2024	BUY	$26.68 - $38.23 $183,985 - $263,634	6,896 New	6,896 $205,000
Q4 2020 Jun 22, 2023	BUY	$26.68 - $38.23 $183,985 - $263,634	6,896 New	6,896 $205,000
Q4 2020 Mar 22, 2023	BUY	$26.68 - $38.23 $183,985 - $263,634	6,896 New	6,896 $205,000
Q4 2020 Feb 16, 2021	BUY	$26.68 - $38.23 $183,985 - $263,634	6,896 New	6,896 $206,000

Others Institutions Holding KRON

# of Institutions

Shares Held

20.7M

Call Options Held

31.4K

Put Options Held

Vida Ventures Advisors, LLC

2.77M
Shares

$2.68 Million
3.24% of portfolio
Vanguard Group Inc Valley Forge, PA

1.92M
Shares

$1.87 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.86M
Shares

$1.8 Million
0.0% of portfolio
Partners Capital Investment Group, LLP Boston, MA

1.67M
Shares

$1.62 Million
0.04% of portfolio
Alphabet Inc. Mountain View, CA

1.44M
Shares

$1.4 Million
0.11% of portfolio

View Full List

About Kronos Bio, Inc.

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $55.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

More about KRON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account